Florida Senate - 2017 COMMITTEE AMENDMENT
Bill No. PCS (832708) for CS for SB 406
Ì427570)Î427570
LEGISLATIVE ACTION
Senate . House
Comm: RCS .
04/27/2017 .
.
.
.
—————————————————————————————————————————————————————————————————
—————————————————————————————————————————————————————————————————
The Committee on Appropriations (Bradley) recommended the
following:
1 Senate Amendment (with title amendment)
2
3 Delete lines 330 - 339
4 and insert:
5 treatment is discontinued; and
6 (f) Maintains a patient treatment plan that includes the
7 dose, route of administration, planned duration, and monitoring
8 of the patient’s symptoms and other indicators of tolerance or
9 reaction to the low-THC cannabis or medical cannabis;
10 (g) Submits the patient treatment plan quarterly to the
11 University of Florida College of Pharmacy for research on the
12 safety and efficacy of low-THC cannabis and medical cannabis on
13 patients;
14 7.(h) Obtains the voluntary written informed consent of the
15
16 ================= T I T L E A M E N D M E N T ================
17 And the title is amended as follows:
18 Delete line 17
19 and insert:
20 supply; eliminating the requirement that physicians
21 maintain patient treatment plans and submit the
22 treatment plans to the University of Florida College
23 of Pharmacy; requiring written consent of a parent or
24 legal